LIXT Shifts Focus to AI Energy Infrastructure, Adds Stuart Porter to Board, Targets Power Equipment & Services for Hyperscale Data Centers
Lixte Biotechnology Holdings, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $6.25
+7.2% in 1h after detection
Post-detection moves
1h
+7.2%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS